Author response: Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: The MIRROR study
- PMID: 30858245
- DOI: 10.1212/WNL.0000000000007085
Author response: Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: The MIRROR study
Comment on
-
Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: The MIRROR study.Neurology. 2018 May 15;90(20):e1805-e1814. doi: 10.1212/WNL.0000000000005516. Epub 2018 Apr 25. Neurology. 2018. PMID: 29695594 Free PMC article. Clinical Trial.
-
Reader response: Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: The MIRROR study.Neurology. 2019 Mar 12;92(11):542-543. doi: 10.1212/WNL.0000000000007084. Neurology. 2019. PMID: 30858244 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical